Eran Ovadya
Directeur Financier/CFO chez NUREXONE BIOLOGIC INC.
Fortune : 198 475 $ au 30/04/2024
Postes actifs de Eran Ovadya
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Directeur Financier/CFO | 15/06/2022 | - |
Historique de carrière de Eran Ovadya
Anciens postes connus de Eran Ovadya
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VVT Medical Ltd. | Directeur Financier/CFO | - | - |
Silexion Therapeutics Ltd.
 Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Directeur Financier/CFO | - | - |
Statistiques
Internationale
| Israël | 3 |
| Canada | 2 |
Opérationnelle
| Director of Finance/CFO | 3 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NUREXONE BIOLOGIC INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. BiotechnologyHealth Technology Silenseed Ltd. operates as a biopharmaceutical company. Its programs include SiG12D-LODER for pancreatic cancer, and Prostate-LODER, GBM-LODER for brain cancer. The company was founded by Dr. Amotz Shemi and Prof. Eithan Galun on November 30, 2008 and is headquartered in Modi’in, Israel. | Health Technology |
| VVT Medical Ltd. |
- Bourse
- Insiders
- Eran Ovadya
- Expérience